5-Bromo-6-[(but-3-yn-2-yl)amino]pyridine-3-carboxylic acid

Catalog No.: 
ACPQXD844
CAS No.: 
1862195-78-5
Molecular Formula: 
C10H9BrN2O2
Molecular Weight: 
269.10
5-Bromo-6-[(but-3-yn-2-yl)amino]pyridine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$308.00InquiryInquiry
1g95%$947.00InquiryInquiry
5g95%$4688.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-6-[(but-3-yn-2-yl)amino]pyridine-3-carboxylic acid
IUPAC Name5-bromo-6-(but-3-yn-2-ylamino)nicotinic acid
Molecular FormulaC10H9BrN2O2
Molecular Weight269.10
SMILESO=C(C1=CC(Br)=C(NC(C#C)C)N=C1)O
InChI KeyRJMAIXOFGDDWLN-UHFFFAOYSA-N
Synonym5-Bromo-6-(but-3-yn-2-ylamino)pyridine-3-carboxylic acid;3-Pyridinecarboxylic acid, 5-bromo-6-[(1-methyl-2-propyn-1-yl)amino]-
CAS No.1862195-78-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPQXD844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFTDI193 route compound structure diagram
    ACFTDI19342105-26-0In Stock
  2. Plus
  3. ACAOHD847 route compound structure diagram
    ACAOHD84729241-62-1In Stock
  4. Then
  5. ACPQXD844 route product structure diagram
    ACPQXD8441862195-78-5
Inquiry

2. ACPQXD844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPQXD844 route product structure diagram
    ACPQXD8441862195-78-5
Inquiry

3. ACPQXD844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPQXD844 route product structure diagram
    ACPQXD8441862195-78-5
Inquiry

Comments (0)